Such as, the paper authors say we would not have enough concrete specifics of the real benefits of microdosing versus placebo effects, risks of microdosing, or what dose is sufficient to develop benefits. Restricting microdosing analysis to subjects that have been investigated in full-dose investigation could prematurely overlook unpredicted and p